Head wound study a bonus for AMS

A NEW medical study in the US has highlighted the effectiveness of Advanced Medical Solutions’ Liquiband skin adhesive in healing scalp lacerations.

The study, from the University of Florida-Jacksonville’s College of Medicine, demonstraed the effectiveness of liquiband on closing scalp wounds. The company said that the product had been successfully used for this purpose in Europe for more than ten years, but that this was the first study in the US that specifically addressed the use of dermal adhesives in closing scalp wounds.

The physicians involved in the study found that LiquiBand® treated scalp wounds very effectively, giving an average score of 4.67 out of 5. Patients reported very low pain scores during the procedures, and all parties indicated that they would use LiquiBand® again rather than traditiional staples or sutures.

Chris Meredith, chief executive officer of AMS, said: “This small pilot study clearly supports what we already knew, namely that LiquiBand® can be used safely for rapid closure of simple scalp lacerations with minimal pain and excellent cosmetic outcomes.

“However, the key aspect of this study is that it is the first of its kind in the US. The results pave the way for a larger prospective study to be undertaken, but we believe that the high levels of reported physician and patient satisfaction should give direct support to the already encouraging marketing initiatives of our partners in that key market.”